Replay available

GSP Crop Science (NSE:GSPCROP) Q2 2027 Earnings Call

GSP Crop Science (NSE:GSPCROP) Q2 2027 earnings call, held 2026-11-16. Watch the replay and read the transcript on 6ix.

Mon, November 16, 2026 at 7:48 AMendedReplay
GSP Crop Science (NSE:GSPCROP) Q2 2027 Earnings Call
Company
GSP Crop Science Limited (NSE:GSPCROP)
Period
Q2 2027 earnings call
Date
Mon, Nov 16, 2026, 7:48 AM ET
Replay
Watch the replay on this page · 33 min

On 6ix: 6ix.com/event/gsp-crop-science-limited-gspcrop-q2-2027-earnings-call

Replay

Transcript

Automated transcript · Written by software from the replay's audio. It can mishear names and figures; the replay is the record.

0:01 Ladies and gentlemen, good morning, and welcome to the GSP Crop Science Limited Q2 and H1 FY 'twenty seven Earnings Conference Call. As a reminder, all participant lines will remain in a listen only mode, and there will be an opportunity for you to ask questions after the management's opening remarks. Please note that this conference is being recorded. Before we proceed, please note this conference call may contain forward looking statements about the company, which are based on the beliefs, opinions and expectation of the company as of date of this call. These statements are not the guarantee of future performance of the company, and it may involve risks and uncertainties that are difficult to predict.

0:51 I will now hand the conference over to the management of Crop Science Limited for opening remarks. Thank you. And over to you, sir. Good morning, everyone, and thank you for joining us today for the GSP Crop Science Limited q two and h one FY twenty seven earnings call. I am Shail Shah, executive director of finance and CFO of the company, along with our Investor Relations team from Head Factors. I hope you all have had the opportunity to review our financial results. The company recorded approximately 20% revenue growth in the Q2 FY 'twenty seven, navigating industry headwinds while sustaining its growth momentum. The first half of 'twenty seven was has been very challenging for the agrochemical industry with uneven rainfall and cost pressures across the industry affecting market conditions.

1:45 Despite the below normal monsoon, Kharif slowing remained broadly stable. But however, the prolonged dry spells in the states like Maharashtra, Karnataka have raised concerns over the final crop productivity. While lower reservoir levels in the Southern India could affect the irrigation availability. A monsoon season has been had had a bearing on agriculture activity across the country. This has been a year where the cumulative rainfall is is for IMD has been at around 87% of the long period average, which is the lowest market, the lowest level since 2015 with Al Nino contributing to the deficit.

2:31 The outlook for the coming months also remains a concern as Alnino is expected to peak in November, while below normal rainfall is anticipated across most parts of the country during October to December. Against this backdrop, the early season could also face challenges due to declining soil moisture and lower reservoir levels in some regions, potentially affecting irrigation availability and growing decisions. This could influence the acreage and output of key winter crops, including beets, pulses, oilseeds and implications of agricultural input demand, including crop protection stocks. But against this backdrop, would like to, you know, appraise the investors about the financial and operational performance of the company.

3:20 So at GSP, we have been managing input costs while maintaining the product quality and operational efficiency with key focus. We continue to monitor raw material price movements and supply conditions globally while working to navigate cost pressures and respond to changing market requirements. As a research driven agrochemical company with over four decades of experience, GSP continues to focus on developing and manufacturing both technical grade active ingredients and finished formulations. Our integrated manufacturing capabilities and investment in backward integration remain important in improving operational efficiency and strengthening our supply chain. Innovation continues to be a key part of our strategy. We are focused on expanding our product pipeline, developing differentiated formulations and introducing patented products that address farmers' changing crop protection needs.

4:10 We believe these efforts will help us remain competitive and create value over the long term. Going forward, weather conditions, farmer demand, fertilizer availability and raw material prices will remain important factors for the agricultural input industry. Our focus will continue to be on cost management, operational efficiency, product development and strengthening our presence in domestic and international markets. Considering the vulnerability and the volatility that has been there, it becomes more important for us to use our innovation capabilities to bring more solutions to farmers wherein in this difficult time wherein the weather is uncertain, we are able to provide better solutions to farmer to increase their yield and sustain in this environment.

5:00 Coming to our financial performance of Q2, the revenue from operations stood at $5.58 crores, registering a growth of 19.5% over the corresponding quarter last year. Growth across the key products was mainly driven by increased realizations, which was also because of the increased increase in the pricing of raw materials. The EBITDA for the September quarter stood at INR 73.6 crores compared to INR 93.2 crores in the previous year. In Q2 FY 'twenty one, the EBITDA margin stood at 13.2%. Overall, the profitability during the quarter was primarily impacted by higher raw material procurement costs, supply related challenges and the lower contribution from higher margin products. However, some cost optimization measures helped improve EBITDA sequentially.

5:49 The profit after tax stood at INR 44.6 crores in Q2 vis a vis INR 58.5 crores in Q2 FY 'twenty six. If you have to look at H1 numbers, the revenue from operations have increased by almost 12% to INR $9.44 crores. The EBITDA stood at INR 116 crores over INR 135 crores of last year. The EBITDA margin stood at 12.3% in h one twenty... H one of FY twenty seven. Other income during the period was higher primarily due to the gains from the sale of fixed assets and foreign exchange gains. The profit after tax stood at 71 crores. I think that is all from our side. Thank you so much. Thank you.

6:37 Ladies and gentlemen, we will now begin with a question and answer session. Anyone who wishes to ask a question may press star and one on their touch tone telephone. If you wish to remove yourself from the question queue, you may press star and 2. Participants are requested to use their handsets while asking a question. Ladies and gentlemen, we will wait for a moment while the question queue is handled. We take the first question from the line of Mayuresh Rao from Invest for Value. Please go ahead. Yeah. Thank you, sir, for the opportunity. Sir, my first question is that due to pollution that is passed on the output, so how wide is our product portfolio to address this and our presence has got market share?

7:27 Hi, Harish. Good morning. Thank you for your question. So we have presence in a Ravi market in micro crops, say, like fruits, vegetables and fuel for pulses. We have also recently launched one of our insecticide patent in insecticide, which is helping us in this ruby time. So our overall, we are a carrier dominated company and Ravi has not been a bigger share of our business. But with the introduction of these patented products and the overall penetration into different geographies, with the expanded network, we expect that we'll be able to do at least better over last year in the Rabi season also despite the challenges that we have been seeing at the macro environment level.

8:21 Yeah. So that... I wanted to follow-up on that only that the... Some new radicals suggested that's going off roughly season is likely to normalize in next few quarters. So what is your view on that, and what is the ground reality for that? Yes. The... Soaring has been impacted. There has been some delays and there is some specific geographies wherein we are seeing the impact delay in. The expectation that it could normalize is there. Everybody is hopeful. At the ground level, so we are seeing particularly in the South where we are seeing certain challenges as the reservoir and the dam has has not been filled. So the farmers are a bit hesitant in terms of the second crop they have to take. But overall, say, crops like chilies in Maharashtra grapes and other pulses, we don't see that that is much of a challenge. But yes, there is maybe a second patty is where we see that there could be some challenge.

9:22 But as as everybody is hopeful that it should get normalized in in this month or, say, another thirty days. Now... Okay, sir. And sir, which e crops and geographical markets could be most affected by expected annual conditions and below normal rainfall? And again, how are these changing weather patterns influencing farmers' spending behavior and demand for agrochemical products? Yes. So particularly, if you could talk about this year, so Maharashtra... Parts of Maharashtra was one area which was very much impacted. Karnataka was impacted along with other parts like Andhra and Angana.

10:07 Even in East, there were certain specific pockets where rainfall was a constraint. This weather pattern, the change of the weather pattern has impacted the farmers in a way that they are delaying their swing to some extent in order to get more visibility in terms of how they can, you know, have an arbitrage or how they can have a risk assurance about their profits. So they are trying to delay the swing. Number two, are seeing that some... There are some 5% to 10% changes in the crops also in the region that have been there, which have been swapped by a less water required crop or a shorter crop. So that the uncertainty is lesser.

10:53 So these are the few changes that we see. In terms of agrochemical spend, you know, being in the crop protection, we see that we typically tend to come into the play at a later stage of the crop while the seeds and the fertilizers are over. So there, once their crop is forty five, fifty days old and the farmer is a bit confident that, you know, now the crop will survive, there the farmer is inclined to spend towards crop protection because that is how we can save or increase his yield. But if there are any chances where, you know, they see that in the early stages where because of a huge gap or a deficit in the early days where the rain is not sufficient, then the farmers are a bit reluctant to use it because they don't see that visibility of the crop surviving the entire cycle. So these are the broad changes that we have seen in the current year.

11:53 Thank you, sir, for so much detailed explanations. And one last question. So like in last on call, you had highlighted the challenges in Brazil due to delayed customer buying liquidity constraints and competition from Chinese suppliers. So while we are seeing that 20% growth in international business, could you provide an update on the sustainability of this growth, and how are we progressing with new registration and distribution partnerships in Brazil, Latin America, and other international markets? Or then, like... And the overall growth over the next two, three years? Sure. So the growth has been predominantly in the domestic markets and not in export markets. So it is a company that we registered.

12:40 And particularly in Brazil, what we have seen is that now the crops are normalized. They are also facing issues due to weather changes. Logistics has been a challenge for international business, particularly availability of vessels and the extra time for the consignment to reach Brazil has been areas where Indian suppliers are facing constraints. So that is where we are navigating the things along with the increased cost pressure. Overall, with having a registration portfolio or, you know, trying to develop a basket of products for Brazil, we have had few investments in registrations while we are, you know, creating our own registrations and acquiring few registrations in Brazil. Two to three years timeline, we see that we'll be doing sizable business in this geography once you have acquired decent number of registrations with a good enough, you know, variability in the portfolio that we have to offer to that market.

13:45 Thank you so much, sir, for such a detailed explanation, and good luck for the future. Thank you. Thank you, Harish. Thank you. We take the next question from the line of Anilud Sharma from Aecon Investments. Please go ahead. Good morning, Am I audible? Yeah. Good morning. You're audible? Yeah. I just had a few questions. So so firstly, the company currently has a presence across across 37 countries. So what are the key markets driving the export growth? The key markets driving export growth are Latin America and Southeast Asia. These are the two areas where we have seen growth coming in. Latin America, particularly being the area where we also we are aligning our investments, and we see that as as I mentioned in the earlier question also that over a period of two, three years, we see that this area will be contributing a good portion of our business in the exports. Okay.

14:51 And sir, how is the company progressing with its expansion plans in Brazil and other Latin American markets? So we have established a subsidiary over there since the three years, and we have been taking our registrations over there. And we have seen that... You know, we have gathered quite a few number of registrations over there. We have also established a small administration office in order to do some b to b business. And we see that at least a year or two, we will take to set up a platform where, you know, we can then scale up our business, particularly in Brazil. And from Brazil, even to other Latin American countries with Brazil as a base. Okay. Understood. So, sir, what is the current contribution of exports to exports to overall revenue, and what is your targeted contribution over the medium term?

15:48 So currently, exports is almost 20% of our total business. And we see that going forward in the three years' time, this could go up to 25%. With, you know, as the growth is also being planned for the domestic business, Proportionately, we see that there will be growth in domestic also. And there could be a 5% proportionate increase in the export business overall as a part of the total contribution in the revenue. Okay, sir. And one last question from my side. How does the management view the growth opportunity in international markets, particularly in patented products and differentiated formulations? Yes. So, I mean, that is where, you know, we...

16:39 Our forte lies. So the entire idea is to have a replica of the business that we have in India, wherein we are selling differentiated products and the patented formulations here. We try to get the patented products, get the patent in international markets also, say, markets like Brazil and other parts of the world where patient is also long term process. Sometimes it takes five, seven years. And as the product is established in India and you've seen the response from the farmers and the fantastic results that we have on the ground, with that background, we take to this... We plan to take these products to the world important markets and register them. So the registration of these patented products has already been on since last three years. Maybe a couple of two to three years down the line, we'll see these registrations coming in with IPR protection so that we are able to maintain our margins also in these markets.

17:35 Okay, sir. Understood. So that's it from my side, sir. Thank you for the opportunity. Thank you. Thank you. Participants who wish to ask a question, please press star and one. We take the next question from the line of Mahesh Kumar from MU Investment. Please go ahead. Hello? Am I audible, sir? Hello? Am I audible? Yes. Yes. So, sir, my first question will be on the revenue growth. So we have seen a good growth in the... This quarter and, you know, h one as well. So what were the key drivers for this growth and how sustainable you think the growth momentum is? Yes. So the key drivers for the growth were that our b two b business, particularly.

18:23 We have seen the domestic b two b business where we have seen good growth, and we have seen growth in our b two c business also. But the growth majorly that we are seeing is coming from domestic b two b business. And, you know, it is only because of this that the growth of business or the increase in the revenue is not very much reflected in the bottom line because the growth in the b two b, there are lot of cost pressures that were there with the increase in the raw material cost. So because of which the GP margins have declined to certain extent because of which the conversion of that increased revenue could not happen at the bottom line. Okay. And this growth, sir, was it volume led or realization led?

19:11 Majorly realization led. And and in some products, some volumes have also increased. Oh, okay. And, sir, on the demand environment across domestic and international market, any comments for the first half of FY twenty seven? So demands are particularly, say, while the beginning of the year was quite okay, but we know when the sentiment started coming in regarding Alino, the demand started to drop. And particularly from... Since July, it was okay, but August, September being very dry. The entire placement or the inventory that was there in the market, the main focus was more towards liquidation. So the demand was a bit subdued in the domestic market, both at the b two b as well as b two c levels Because every, you know, every company and even in our distributors were having a endeavor that how do we liquidate the stock that we are having at the farmer level and to make sure that, you know, the the crop is protected.

20:15 So that was the case. Okay. Okay. And thank you, sir. I'll run back with you and all the best. Thank you. Thank you. Participants, reminder, if you wish to ask a question, please press star and 1. We take the next question from the line of from GM Investments. Please go ahead. Hello. Yes. Good morning. I hope I'm audible. So thank you for the opportunity. I have two questions. One being, what proportion of the company's raw material requirements is currently being imported? And how does the management plan to reduce its dependency?

21:03 Yes. So almost 40 to 45% of our total router requirement is imported. It is imported from China. And as you know, we have already set up a plan for backward integration. And we are continuously in the process of... Our R and D is in the process of developing products, wherein, you know, we can... For our active ingredients and technicals, we can have backward integration opportunities wherein we can reduce the reliance on import and also have a consistent supply chain along with, you know, better margins as we'll able to cover a better value chain across the product line. So that is the idea.

21:49 Okay. Sir, next, what are the key priorities for us over the next two to three years? The key priorities are, number one, to increase the base of our patented portfolio that we have in the domestic market, both for our b two c as well as b two b business. So we plan to grow big on this number, establish the... Whatever established products we have, we want to scale it further to launch new patented formulations in different segments to have better market presence and market share in different geographies. Number two priority will be to reap our benefits or of the investments in Brazil geography wherein, you know, we have acquired registrations and we have invested certain amounts in registrations.

22:37 And the third being to strengthen further our r and d to increase the cost competitive advantage by doing backward integration of key technical that we manufacture. So these are the three key priorities that we as a company have. Okay. That looks nice, sir. Further, if I can ask another question, what are the key growth drivers that the management is expecting to support our revenue and profitability in the remaining FY twenty seven and forward looking? Yeah. So the key growth drivers are, you know, the patient formulation that you've just launched last month. In the Rabi business, we see that this product will be positioned well considering the agroprimatic condition that is there. It is a product which will help the farmers as well as the crop to boost production.

23:32 So we see that product driving the growth along with it as it being an anchor product, other products will also move in that market. Secondly, forward looking what we see is that we are establishing certain anchor brands based on which we are planning to set up the products around that anchor brands. So that the overall market where we want to be present at different geographies, we can penetrate the market further and increase our distribution network to that extent. So that is the key growth drivers that we see coming in. Okay.

24:17 Thank you so much, sir, for answering the question for patiently. Thank you for the opportunity. Thank you. Thank you. We take the next question from the line of from family office. Please go ahead. Yes, sir. Good morning, sir. I'm audible. Good morning. Yes. You're audible. Yeah. So my first question is regarding... So if you see despite our revenue growth being 19.5% in q two, and EBITDA has also declined by 21%. So I just want to know what were the key factors during the contraction in operating profitability? So two broad things. One is increase in the raw material cost that was there. So we see that the the gross margins have decreased.

25:06 And secondly, in the operating cost, we have seen certain cost like power and fuel where we see that the cost have increased along with the escalation in the manpower cost that is a part of a routine annual exercise. So these are the few reasons by which the EBITDA is contracted. Majorly these two reasons, raw material cost and power and fuel cost increase. Got it, sir. Sir, how much of this margin pressure was attributable to higher raw material cost versus supply chain tenders and lower sales of high margin products, respectively? We can say almost 50% of the margin pressure was because of the raw material cost.

25:55 Remaining the 20, 30% was because of the supply chain related issues or cost and remaining 20% being the other factors of the high margin products, etcetera. Got it, sir. And if you see the gross profit as marginal declined from 40% to 34. So when can we expect the margins to stabilize going forward? So we see that, you know, another quarter or so, we see that it could be, you know, where there could be certain pressures further. But I think in the q four, we could see that the margins again coming up back to the normal levels.

26:43 Alright, sir. So couple last questions, please. So if you see, how does GSP differentiate its product from competing domestic and multinational hydro chemical manufacturer? So we try to create a unique combination of formulation from the existing and the newer chemistries that are available, and we try to patent them. So if there is one particular... To give you an example, say, if there is a product called chlorotenical, it was product which went off patent and we were the first ones to come under $9.03. With the chlorotenipol, we have certain patented combinations that we have. Now these patented combinations help further Fatma to solve multiple problems by using one product.

27:32 And it helps us to create a niche in that market where we are able to differentiate from other existing products or generic data there. So that is how we try to develop synergistic combinations where we are able to give a more value added product at a farmer's level for them to solve multiple problems or for them to have a better coverage in terms of time. So that the spray cost that is there reduces, either due to reduction in number of springs or due to the coverage of the crop that is there. Right, sir. So also I'm wondering about what is the current level of our investment in IT and does management intending to increase this investment in future?

28:19 Sorry. I couldn't get your question. Yeah. So sorry. One, I want to know about what is the current level of our investment in r and d, And is the management intending to increase this investment in future? Yes. So current level of investment in r and d is around two two and a half percent of the revenue. And we plan to increase it going forward considering the type of products and the backward integration plans that we have. So maybe next year onwards, we could see some increase in the investment in r and d. Got it, sir. That's it, sir. Thank you so much, sir, for your input. That answers my question, and I wish you all the very best. Thank you so much.

29:08 Thank you. Participants who wish to ask a question, please press star and 1. We take the next question from the line of Neha Chen, an individual investor. Please go ahead. Hello? Hi, sir. Hi, sir. Good morning. So just wanted to check that, you know, that h one f y 27 pack has declined roughly by 12 percentage despite the revenue growth. So what were the key factors affecting this performance? So the key factors were there's a decrease in the gross margin because of the increase in the raw material cost, And that is the key factor for which the...

29:54 Which has been also reflected at the fact level, along with some increase in the operating cost because of the increase in the power and fuel prices that were there. These are the two reasons by which the margins have declined over last year. So, sir, do we see it increasing going forward once these prices stabilize? Yes. We see that, you know, q three could be something, which could be a subdued one. But q four is where we see that the prices as well as the overall realizations will improve with the upcoming season forecast that will be there. So we see that it will normalize in q four. Okay. So got it. And, sir, coming to the other income, which has the... Which has increased this half year, I think, of some fixed that had failed.

30:42 So what do we see as a normalized level of other income? Apart leaving apart these fixed assets, etcetera? So typically, the other income would be in the range of, say, 20,000,000 or so other than... So that would be the normalized one. The one as you rightly mentioned is the additional that is because of the sale of fixed asset. A land parcel was sold. Alright, sir. And, sir, right now, you know, as we were discussing about that margin, so similarly, on EBITDA margin, this has improved on sequential basis. So should we expect this improvement to continue in the coming quarters? Yes. EBITDA margin should improve sequentially in the coming quarters considering the kind of products that we have planned for Ravi and the q four being the pre placement period that is there.

31:38 So so just last question, follow-up. Does this mean that q four margins will be better than q three like you previously mentioned for? Right? Yes. Sure. Sure. Okay. Thank you so much, sir. Thank you. And good luck. Thank you. Thank you. Participants who wish to ask a question, please press star and one. Participants who wish to ask a question, please press star and one. Participants, we will wait for the question queue to assemble. Please stay connected. As there are no further questions from the participants, I will now have the conference over to mister for closing comments.

32:32 Yes. Thank you, everyone, for joining the call, and we look forward for having you in the next call. Thank you. Thank you. On behalf of GSP Crop Science Limited, that concludes this conference call. Thank you for joining us, and you may now disconnect your lines.

Follow GSP Crop Science Limited into a list and get an email when it puts out news.

Latest news releases

Companies on this call

More from GSP Crop Science Limited